Articles tagged with 'Business & Finance' | Bayer

Newsroom Bayer (Business & Finance)

2023
September
21,
2023
| 10:59 AM Europe/Amsterdam
Agreement with UK-based NIAB to acquire their strawberry pipeline and commercial portfolio / Focus on large-scale professional strawberry growers to meet growing consumer and retail demand / The program will continue to be based in Kent, UK...
Read more
September
21,
2023
| 08:29 AM Europe/Amsterdam
The investment supports Bayer’s sustainability goal to help provide 100 million women in low- and middle-income countries with access to modern contraception by 2030 / The company’s facility in Turku will utilize automation, robotics, and digital tec...
Read more
September
20,
2023
| 17:59 PM Europe/Amsterdam
New issue of two tranches with a non-call period of 5.25 and 8.25 years, respectively, combined with a tender offer for two of Bayer’s existing hybrid bonds
Read more
August
30,
2023
| 14:59 PM Europe/Amsterdam
Largest single investment in Crop Protection in Germany for 40 years / Focus on Environmental and Human Safety / State-of-the-art lab building and greenhouse / 5 floor main building; 28,000 m2 gross floor area / R&D facility offers space for 200 empl...
Read more
August
29,
2023
| 13:59 PM Europe/Amsterdam
New agreement will focus on CRISPR applications for Bayer’s Preceon™ Smart Corn System / Collaboration builds on successful initial gene-editing partnership between the two companies that resulted in 27 novel traits being transferred into Bayer’s tes...
Read more
August
22,
2023
| 13:59 PM Europe/Amsterdam
Berlin, August 22, 2023 – Bayer today announced Juergen Eckhardt MD, MBA as the new Head of Business Development & Licensing / Open Innovation (BDL/OI) of its Pharmaceuticals Division effective September 1, 2023. He will join the Pharmaceuticals Exec...
Read more
August
21,
2023
| 16:44 PM Europe/Amsterdam
Leverkusen, August 21, 2023 – The Supervisory Board of Bayer AG has unanimously appointed Heike Prinz to Bayer’s Board of Management effective September 1, 2023. She will become the company’s Chief Talent Officer and Labor Director. This follows the ...
Read more
August
08,
2023
| 07:29 AM Europe/Amsterdam
Group sales fall by 8.2 percent (Fx & portfolio adj.) to 11.044 billion euros / EBITDA before special items: 2.527 billion euros (minus 24.5 percent) / Crop Science business down significantly, mainly due to sharp decline in glyphosate volumes and pr...
Read more
July
24,
2023
| 19:33 PM Europe/Amsterdam
Leverkusen, July 24, 2023 – The Bayer Group adjusted its full-year outlook for 2023 downward on Monday, mainly due to a significant further decline in sales of glyphosate-based products.For full-year 2023, Bayer now anticipates sales of between 48.5 ...
Read more
June
20,
2023
| 13:29 PM Europe/Amsterdam
Expectation to tap into more than 100 billion euros of value in accessible and ag-adjacent markets  / Unparalleled pipeline with estimated peak sales potential of more than 30 billion euros to promote regenerative agricultural practices and enable fa...
Read more
June
05,
2023
| 08:30 AM Europe/Amsterdam
Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer’s gene therapy portfolio / High potency ionizable lipid technology and LNP carriers allow for efficient, targeted, and transient delivery of gene editing ...
Read more
June
01,
2023
| 08:29 AM Europe/Amsterdam
Exclusive license agreement includes rights to develop and commercialize Cedilla’s CyclinE1/CDK2 inhibitors / Assets are currently in pre-clinical development with potential to serve patients with high unmet need in underserved indications / Collabor...
Read more
May
23,
2023
| 19:07 PM Europe/Amsterdam
Issuance consisted of three tranches with maturities between 3.25 and 10 years and was substantially oversubscribed
Read more
May
16,
2023
| 13:11 PM Europe/Amsterdam
Funding advances BBI-355, a potentially best-in-class checkpoint kinase 1 (CHK1) inhibitor, through meaningful clinical data readouts in Phase 1/2 POTENTIATE clinical trial
Read more
May
11,
2023
| 07:29 AM Europe/Amsterdam
Group sales stable at 14.389 billion euros (Fx & portfolio adj. minus 1.1 percent)o   Accelerated normalization in glyphosate business – good price dynamics in other Crop Science unitso   New Pharmaceuticals products deliver strong growth – headwinds...
Read more
May
11,
2023
| 07:29 AM Europe/Amsterdam
Four oral presentations and seven poster presentations will share insights into AskBio’s adeno-associated virus research, development and pre-clinical product progress / Breadth of research reinforces AskBio’s continued commitment to the development ...
Read more
May
10,
2023
| 12:59 PM Europe/Amsterdam
Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the company in oncology / Advancing the use of bicycle peptides as a novel targeting approach in radiopharm...
Read more
May
04,
2023
| 22:15 PM Europe/Amsterdam
Global Bayer Co.Lab network of life science incubators established to accelerate innovation and foster collaborations within vibrant biotech ecosystems / U.S. flagship location opening in Cambridge, MA, encompasses state-of-the-art laboratories and c...
Read more
April
28,
2023
| 09:59 AM Europe/Amsterdam
Substantial sales and earnings growth in 2022 / Dividend of 2.40 euros per share proposed – up 20 percent / Baumann to retire at the end of May – Bill Anderson designated as his successor
Read more
April
05,
2023
| 07:44 AM Europe/Amsterdam
Company was part of delegation led by German Vice-Chancellor Robert Habeck to Kyiv this week / Bayer underscores commitment to Ukraine and to help rebuild the economy / Investment adds to earlier 200 million euro spending for seed production and mult...
Read more
March
14,
2023
| 12:59 PM Europe/Amsterdam
Ready-to-use AgPowered Services from Bayer running on the new Microsoft Azure Data Manager for Agriculture / Readymade capabilities and robust digital infrastructure allow innovators to focus on differentiated value / Companies, farmers and consumers...
Read more
March
09,
2023
| 16:14 PM Europe/Amsterdam
Research Triangle Park, N.C.– March 9, 2023 – Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become the company’s next Chief Executive Officer (C...
Read more
February
28,
2023
| 07:30 AM Europe/Amsterdam
Group sales increase 8.7 percent (Fx & portfolio adj.) to 50.739 billion euros / EBITDA before special items rises 20.9 percent to 13.513 billion euros, largely driven by exceptionally strong performance at Crop Science / Pharmaceuticals increases sa...
Read more
February
13,
2023
| 08:29 AM Europe/Amsterdam
Closing follows announcement of acquisition on January 18, 2023 / Acquisition bolsters Bayer’s position in digital medical imaging / Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneur...
Read more
February
08,
2023
| 17:14 PM Europe/Amsterdam
Leverkusen, February 8, 2023 – The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimo...
Read more
January
19,
2023
| 11:59 AM Europe/Amsterdam
Oerth’s unique PROTAC® protein degradation technology is expected to be a new, game-changing generation of more sustainable crop protection products / The agreement recommits to the combination of Oerth Bio’s specialized expertise designing PROTAC® d...
Read more
January
18,
2023
| 08:29 AM Europe/Amsterdam
Acquisition is part of Bayer’s innovation strategy in radiology / Blackford Analysis provides cutting-edge radiology AI (artificial intelligence) platform technology / Following closing of the acquisition, Blackford Analysis to become part of Bayer’s...
Read more
January
10,
2023
| 14:59 PM Europe/Amsterdam
Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells
Read more
January
10,
2023
| 13:59 PM Europe/Amsterdam
Strong market uptake of Nubeqa™ and Kerendia™ / Asundexian projected peak sales of more than five billion euros as treatment option for thrombosis and stroke prevention  / High-value late-stage development portfolio  / Positive study outcomes from ce...
Read more